Researchers evaluated the effectiveness of the SARS-CoV-2 vaccination in the IBD population and the potential impact of immunosuppressive medications.
The AGA summarized their responses to the COVID-19 pandemic, with a focus on advocacy and legislative measures.
Researchers analyzed the impact of GI symptoms on COVID-19 disease outcomes and patients’ inflammatory responses.
Researchers aimed to identify differences in outcomes among patients with chronic pancreatitis who receive or do not receive opioids.
A task force from the AAD surveyed members about their perceptions of and experiences with teledermatology during the COVID-19 pandemic and in light of new regulatory changes from the US Centers for Medicare and Medicaid Services.
MIPS scores represent a weighted average of physician performance and link physician remuneration with a number of performance metrics.
Inexpensive, practical, and safe strategies to reduce patients’ pain level during inactivated PRP scalp injections are reviewed.
The British Society of Gastroenterology IBD section and IBD Clinical Research Group has released a position statement on SARS-CoV-2 vaccination guidelines for patients with IBD.
Investigators analyzed the impact of the COVID-19 pandemic on number of GI procedures performed and new cancer diagnoses.
Investigators compared the efficacy of open-label placebo with double-blind placebo in the treatment of patients with IBS.
